Guru K. Viswanathan
Tel Aviv, TA 69978, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The contribution of individual residues of an aggregative hexapeptide derived from the human γD-crystallin to its amyloidogenicity.
Journal: International journal of biological macromolecules
Published: October 25, 2021
Inhibition of amyloid fibrillation of γD-crystallin model peptide by the cochineal Carmine.
Journal: International journal of biological macromolecules
Published: October 29, 2020
An amyloidogenic hexapeptide from the cataract-associated γD-crystallin is a model for the full-length protein and is inhibited by naphthoquinone-tryptophan hybrids.
Journal: International journal of biological macromolecules
Published: January 27, 2020
Tryptophan-glucosamine conjugates modulate tau-derived PHF6 aggregation at low concentrations.
Journal: Chemical communications (Cambridge, England)
Published: November 21, 2019
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Journal: ACS chemical neuroscience
Published: July 09, 2019
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration.
Journal: Cellular and molecular life sciences : CMLS
Published: June 20, 2019
Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides.
Journal: Frontiers in cell and developmental biology
Published: May 26, 2019
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Journal: Cellular and molecular life sciences : CMLS
Published: March 10, 2019
Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid.
Journal: Molecules (Basel, Switzerland)
Published: November 14, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026